Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells - PubMed (original) (raw)

. 2006 May 25;441(7092):475-82.

doi: 10.1038/nature04703. Epub 2006 Apr 5.

Affiliations

• PMID: 16598206
• DOI: 10.1038/nature04703

Free article

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

Omer H Yilmaz et al. Nature. 2006.

Free article

Abstract

Recent advances have highlighted extensive phenotypic and functional similarities between normal stem cells and cancer stem cells. This raises the question of whether disease therapies can be developed that eliminate cancer stem cells without eliminating normal stem cells. Here we address this issue by conditionally deleting the Pten tumour suppressor gene in adult haematopoietic cells. This led to myeloproliferative disease within days and transplantable leukaemias within weeks. Pten deletion also promoted haematopoietic stem cell (HSC) proliferation. However, this led to HSC depletion via a cell-autonomous mechanism, preventing these cells from stably reconstituting irradiated mice. In contrast to leukaemia-initiating cells, HSCs were therefore unable to maintain themselves without Pten. These effects were mostly mediated by mTOR as they were inhibited by rapamycin. Rapamycin not only depleted leukaemia-initiating cells but also restored normal HSC function. Mechanistic differences between normal stem cells and cancer stem cells can thus be targeted to deplete cancer stem cells without damaging normal stem cells.

PubMed Disclaimer

Comment in

• Stem cells: good, bad and reformable.
  Janzen V, Scadden DT. Janzen V, et al. Nature. 2006 May 25;441(7092):418-9. doi: 10.1038/441418b. Nature. 2006. PMID: 16724049 No abstract available.

Similar articles

• PTEN in the haematopoietic system and its therapeutic indications.
  Cheung AM, Mak TW. Cheung AM, et al. Trends Mol Med. 2006 Nov;12(11):503-5. doi: 10.1016/j.molmed.2006.09.002. Epub 2006 Sep 25. Trends Mol Med. 2006. PMID: 16996801
• Stem cells: good, bad and reformable.
  Janzen V, Scadden DT. Janzen V, et al. Nature. 2006 May 25;441(7092):418-9. doi: 10.1038/441418b. Nature. 2006. PMID: 16724049 No abstract available.
• PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
  Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L. Zhang J, et al. Nature. 2006 May 25;441(7092):518-22. doi: 10.1038/nature04747. Epub 2006 Apr 23. Nature. 2006. PMID: 16633340
• PTEN and leukemia stem cells.
  Fragoso R, Barata JT. Fragoso R, et al. Adv Biol Regul. 2014 Sep;56:22-9. doi: 10.1016/j.jbior.2014.05.005. Epub 2014 Jun 14. Adv Biol Regul. 2014. PMID: 24961634 Review.
• A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell.
  Ito K, Bernardi R, Pandolfi PP. Ito K, et al. Curr Opin Genet Dev. 2009 Feb;19(1):51-9. doi: 10.1016/j.gde.2009.01.004. Epub 2009 Feb 11. Curr Opin Genet Dev. 2009. PMID: 19216069 Free PMC article. Review.

Cited by

• The functions and regulation of the PTEN tumour suppressor.
  Song MS, Salmena L, Pandolfi PP. Song MS, et al. Nat Rev Mol Cell Biol. 2012 Apr 4;13(5):283-96. doi: 10.1038/nrm3330. Nat Rev Mol Cell Biol. 2012. PMID: 22473468 Review.
• Somatic stem cell differentiation is regulated by PI3K/Tor signaling in response to local cues.
  Amoyel M, Hillion KH, Margolis SR, Bach EA. Amoyel M, et al. Development. 2016 Nov 1;143(21):3914-3925. doi: 10.1242/dev.139782. Epub 2016 Sep 15. Development. 2016. PMID: 27633989 Free PMC article.
• Transcriptional analysis of histone deacetylase family members reveal similarities between differentiating and aging spermatogonial stem cells.
  Kofman AE, Huszar JM, Payne CJ. Kofman AE, et al. Stem Cell Rev Rep. 2013 Feb;9(1):59-64. doi: 10.1007/s12015-012-9392-5. Stem Cell Rev Rep. 2013. PMID: 22729928 Free PMC article.
• Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
  Hirao A, Hoshii T. Hirao A, et al. Cancer Sci. 2013 Aug;104(8):977-82. doi: 10.1111/cas.12189. Epub 2013 Jun 9. Cancer Sci. 2013. PMID: 23648144 Free PMC article. Review.
• Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.
  Zhang C, Ryu YK, Chen TZ, Hall CP, Webster DR, Kang MH. Zhang C, et al. Leuk Res. 2012 Mar;36(3):342-9. doi: 10.1016/j.leukres.2011.10.022. Epub 2011 Dec 3. Leuk Res. 2012. PMID: 22137317 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • MLibrary (Deep Blue)
  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal